Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.775
+0.215 (4.71%)
At close: Jul 21, 2026, 4:00 PM EDT
4.750
-0.025 (-0.53%)
After-hours: Jul 21, 2026, 5:31 PM EDT
Cingulate Market Cap
Cingulate has a market cap or net worth of $64.31 million as of July 21, 2026. Its market cap has increased by 193.00% in one year.
Market Cap
64.31M
Enterprise Value
42.95M
1-Year Change
193.00%
Ranking
Category
Stock Price
$4.78
ChartMarket Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has increased from $64.29M to $64.31M, an increase of 0.05%. That is a compound annual growth rate of 0.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 64.31M | 119.31% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 68.14M |
| LeonaBio | 67.82M |
| MediciNova | 66.45M |
| ImageneBio | 60.68M |
| Cardiff Oncology | 60.17M |
| TScan Therapeutics | 59.78M |
| Elicio Therapeutics | 59.31M |
| Edesa Biotech | 58.69M |